GlassScriptPhysician profile
Christopher A York
NPI 1821315367
$3,111.62
in general payments reported to CMS, 2019-2025
20 companies · $2,026 in 2025
The $2,026 reported for 2025 was more than what 89% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $104 · 2021: $145 · 2022: $44.67 · 2023: $82.17 · 2024: $580 · 2025: $2,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,688.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $816.64 | 2021-2025 | |
| Inspire Medical Systems, INC. | $624.16 | 2024-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $618.87 | 2019-2025 | Dupixent |
| Medtronic, INC. | $289.35 | 2025 | Propel, Sinuva, Nuvent |
| Glaxosmithkline, LLC. | $224.15 | 2024-2025 | Nucala |
| Optinose US, INC. | $101.29 | 2019-2025 | |
| Neurent Medical Limited | $73.54 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Abbvie INC. | $63.92 | 2024 | |
| Olympus America INC. | $51.90 | 2020-2023 | Rhino-Laryngo Videoscope |
| Phadia US INC. | $48.58 | 2024 | Immunocap |
| Stryker Corporation | $28.42 | 2020 | |
| Jazz Pharmaceuticals INC. | $28.14 | 2019-2020 | |
| Lilly USA, LLC | $26.68 | 2025 | Zepbound |
| Cochlear Americas | $22.54 | 2021 | |
| Ethicon US, LLC | $17.76 | 2025 | Harmonic |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fisher & Paykel Healthcare INC | $17.45 | 2023 | Fisher & Paykel Healthcare |
| Resmed Corp | $15.72 | 2025 | |
| Tactile Systems Technology INC | $14.89 | 2024 | Flexitouch Plus, Entre Plus |
| Lucid Diagnostics INC. | $13.84 | 2024 | |
| Arbor Pharmaceuticals, INC. | $13.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher York listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.